Ergoteles LLC Danaher Corp Transaction History

Ergoteles LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$224.99 - $256.14 $2.91 Million - $3.31 Million	12,929 New	12,929 $3.1 Million
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $1.07 Million - $6.53 Million	-4,333 Reduced 51.94%	4,010 $1.04 Million
Q2 2022 Aug 12, 2022	SELL	$237.11 - $299.66 $665,093 - $840,546	-2,805 Reduced 25.16%	8,343 $2.12 Million
Q1 2022 May 13, 2022	SELL	$257.27 - $315.76 $34.5 Million - $42.4 Million	-134,294 Reduced 92.34%	11,148 $3.27 Million
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $42.5 Million - $47.9 Million	145,442 New	145,442 $47.9 Million
Q2 2021 Aug 12, 2021	SELL	$225.08 - $271.69 $3.06 Million - $3.69 Million	-13,600 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$212.38 - $245.9 $776,248 - $898,764	-3,655 Reduced 21.18%	13,600 $3.06 Million
Q4 2020 Feb 11, 2021	BUY	$212.5 - $245.46 $3.67 Million - $4.24 Million	17,255 New	17,255 $3.83 Million

2,432

563M

3.94M

4.11M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.